Research progress of natural plant polysaccharides inhibiting inflammatory signaling pathways and regulating intestinal flora and metabolism to protect inflammatory bowel disease

被引:11
|
作者
Zhang, Shuai [1 ,2 ]
Zhang, Mingxu [3 ]
Li, Wei [1 ]
Ma, Lina [2 ]
Liu, Xinglong [2 ,4 ]
Ding, Qiteng [1 ,2 ]
Yu, Weimin [1 ,2 ]
Yu, Taojing [1 ,2 ]
Ding, Chuanbo [2 ,4 ]
Liu, Wencong [2 ,5 ]
机构
[1] Jilin Agr Univ, Coll Chinese Med Mat, Changchun 130118, Peoples R China
[2] Jilin Agr Univ, Coll Life Sci, Engn Res Ctr, Chinese Minist Educ Bioreactor & Pharmaceut Dev, Changchun 130118, Peoples R China
[3] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, State Key Lab Qual Ensurance & Sustainable Use Dao, Beijing 100700, Peoples R China
[4] Jilin Agr Sci & Technol Coll, Coll tradit Chinese Med, Jilin 132101, Peoples R China
[5] Wuzhou Univ, Sch Food & Pharmaceut Engn, Wuzhou 543003, Peoples R China
基金
中国国家自然科学基金;
关键词
Natural plant polysaccharides; Inflammatory bowel disease; Gut flora; Short chain fatty acids; ULCERATIVE-COLITIS; GUT MICROBIOTA; MESALAZINE; MESALAMINE; PRODUCTS; MODEL; COLON; MICE;
D O I
10.1016/j.ijbiomac.2023.126799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural plant polysaccharides are macromolecular substances with a wide range of biological activities. They have a wide range of biological activities, especially play an important role in the treatment of inflammatory bowel disease. The molecular weight of polysaccharides, the composition of monosaccharides and the connection of glycosidic bonds will affect the therapeutic effect on inflammatory bowel disease. Traditional Chinese medicine plant polysaccharides and various types of plant polysaccharides reduce the levels of inflammatory cytokines IL-1 beta, IL-6, IL-8 and IL-17, increase the level of anti-inflammatory factor IL-10, regulate NF-kappa B signaling pathway, and NLRP3 inflammasome to relieve colitis. At the same time, they can play a protective role by regulating the balance of intestinal flora in mice with colitis and increasing the abundance of probiotics to promote the metabolism of polysaccharide metabolites SCFAs. This review summarizes the research on the treatment of inflammatory bowel disease by many natural plant polysaccharides, and provides a theoretical basis for the later treatment of polysaccharides on inflammatory bowel disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] An oral nano-antioxidant for targeted treatment of inflammatory bowel disease by regulating macrophage polarization and inhibiting ferroptosis of intestinal cells
    Yang, Jing
    Bai, Yunhao
    Shen, Shuilin
    Tao, Xinyue
    Ma, Chengyu
    Fu, Bowen
    Dai, Qihao
    Wu, Jian
    Meng, Zhengjie
    Sun, Qingmin
    Li, Xueming
    Ren, Hao
    CHEMICAL ENGINEERING JOURNAL, 2023, 465
  • [42] Research progress on the relationship between Paneth cells-susceptibility genes, intestinal microecology and inflammatory bowel disease
    Zhou, Qi-Ming
    Zheng, Lie
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (34) : 8111 - 8125
  • [43] Progress in Understanding the Role of Probiotics and Fecal Microbiota Transplantation in Regulating Inflammatory Bowel Disease
    Tian Y.
    Zhang C.
    Yang T.
    Dai X.
    Liu W.
    Man C.
    Zhang W.
    Jiang Y.
    Jiang, Yujun (yujun_jiang@163.com), 1600, Chinese Chamber of Commerce (42): : 250 - 259
  • [44] Morroniside alleviates lipopolysaccharide-induced inflammatory and oxidative stress in inflammatory bowel disease by inhibiting NLRP3 and NF-κB signaling pathways
    Zhang, Shifen
    Lai, Qiaohua
    Liu, Liming
    Yang, Yajie
    Wang, Juan
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2022, 50 (06) : 93 - 99
  • [45] Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
    Duchmann, R
    Kaiser, I
    Hermann, E
    Mayet, W
    Ewe, K
    ZumBuschenfelde, KHM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 102 (03): : 448 - 455
  • [46] LACC1 regulates changes in the intestinal flora in a mouse model of inflammatory bowel disease
    Xu, Zheng-Yuan
    Wang, Jin-Chun
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [47] LACC1 regulates changes in the intestinal flora in a mouse model of inflammatory bowel disease
    Zheng-Yuan Xu
    Jin-Chun Wang
    BMC Gastroenterology, 23
  • [48] Orally administered neohesperidin attenuates MPTP-induced neurodegeneration by inhibiting inflammatory responses and regulating intestinal flora in mice
    He, Dewei
    Gao, Xiyu
    Wen, Jingru
    Zhang, Yiming
    Yang, Shuo
    Sun, Xiaojia
    Cui, Mingchi
    Li, Zhe
    Fu, Shoupeng
    Liu, Juxiong
    Liu, Dianfeng
    FOOD & FUNCTION, 2024, 15 (03) : 1460 - 1475
  • [49] The role of Th17 cells in inflammatory bowel disease and the research progress
    Chen, Lu
    Ruan, Guangcong
    Cheng, Yi
    Yi, Ailin
    Chen, Dongfeng
    Wei, Yanling
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [50] Research progress on the predictive role of sarcopenia in the course and prognosis of inflammatory bowel disease
    Liu, Yang
    Tian, Linglin
    PEERJ, 2023, 11